aspirin and dipyridamole
- Product NDC
- 0115-1711
- 11-digit product format
- 001151711
- Labeler code
- 0115
- Product ID
- 0115-1711_57150d16-7ee0-470e-a96b-a4e6e92d3c8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aspirin and dipyridamole
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Impax Generics
- Application
- ANDA206964
- Marketing category
- ANDA
- Marketing start
- 2016-08-29
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN; DIPYRI
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Cyclooxygenase
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 0115-1711 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 0115-1711 | 0115-1711-13 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A206964-001 | ASPIRIN AND DIPYRIDAMOLE | ASPIRIN; DIPYRIDAMOLE | 25MG;200MG | CAPSULE, EXTENDED RELEASE / ORAL | | | 2017-01-18 |